Removing Pfizer's Chantix Boxed Warning A One-Off, Committee Says
Executive Summary
Advisory committee says data supports dialing back safety label for the smoking cessation product, but shouldn’t be precedent setting.
You may also be interested in...
FDA Makes Rare Call, Removes Boxed Warning From Chantix, Zyban Labels
Pfizer, GSK score as neuropsychiatric symptom risks now only appear in Warnings and Precautions section following EAGLES trial results.
Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?
FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.
Pfizer's Pitch For Chantix Warning Reduction Focuses On Those With Mental Illness
Those patients need more options for smoking cessation, Pfizer says, but that is the group FDA most worries about when deciding whether to remove its boxed warning.